Brief: Kura Oncology Announces Financing Transactions With Bristol Myers Squibb And Hercules Capital, Providing Access To Up To $150 Million

Hercules Capital

03/11/2022 11:34

Nov 3 (Reuters) - Bristol-Myers Squibb Co  BMY.N :
    * KURA ONCOLOGY ANNOUNCES FINANCING TRANSACTIONS WITH
BRISTOL
MYERS SQUIBB AND HERCULES CAPITAL, PROVIDING ACCESS TO UP TO
$150 MILLION
    * KURA ONCOLOGY INC - PROCEEDS EXTEND KURA'S CASH RUNWAY
INTO
2026, IF TERM LOAN IS FULLY DRAWN
    * KURA ONCOLOGY INC - $25 MILLION EQUITY INVESTMENT FROM
BRISTOL
MYERS SQUIBB AT $18.25 PER SHARE
    * KURA ONCOLOGY INC - TERM LOAN FACILITY FROM HERCULES
CAPITAL
PROVIDES UP TO $125 MILLION
    * KURA ONCOLOGY INC - $25 MILLION EQUITY INVESTMENT FROM
BRISTOL
MYERS SQUIBB AT $18.25 PER SHARE
    * KURA ONCOLOGY INC - TERM LOAN FACILITY FROM HERCULES
CAPITAL
PROVIDES UP TO $125 MILLION
    * KURA ONCOLOGY INC - PROCEEDS EXTEND KURA'S CASH RUNWAY
INTO
2026, IF TERM LOAN IS FULLY DRAWN

Source text for Eikon:  ID:nGNX8hzK7P 
Further company coverage:  BMY.N 
 ((Reuters.Briefs@thomsonreuters.com;))